Prevalence of amblyopia in primary school children in Qassim province, Kingdom of Saudi Arabia

Yousef Homood Aldebasi, Yousef Homood Aldebasi

Abstract

Purpose: To determine the prevalence and causes of amblyopia in primary school children in Qassim province, Kingdom of Saudi Arabia (KSA).

Materials and methods: In this cross sectional study, 5176 children, aged 6 to 13 years (mean - 9.53 ± 1.88 years) were evaluated. There were 2573 (49.71%) males and 2603 (50.29%) females. Distance visual acuity (V/A) was tested monocularly using a logMAR chart with and without correction. Cycloplegic refraction was performed in children with reduced vision. To determine the etiology of amblyopia, children were enrolled if there was a difference in V/A of two or more lines between eyes or an absolute reduction in acuity <20/30 in either eye, that could not be corrected by refraction. P ≤ 0.05 was considered statistically significant.

Results: There 202 out of 5176 (3.90%) with ambylopia. There are 98 (1.88%) amblyopic females. There was no statistical difference in gender for amblyopes (P > 0.05). The prevalence of amblyopia was statistically significant higher in the older age group (10-13 year) compared to younger age group (6 to 9 years) (P < 0.05). Unilateral amblyopia (3.24%) was more frequent than bilateral amblyopia (0.66%). The most frequent causes of amblyopia were refractive error (94.56%), of which anisometropic amblyopia was present in 77.72%, isoametropic amblyopia in 16.84% and strabismus in 5.44%.

Conclusion: The prevalence of amblyopia in Qassim province, KSA, is 3.9% which is similar or higher than other published studies on amblyopia. Anisometropic refractive errors are the most common underlying cause for this population. We recommend implementation of visual screening programs for children with appropriate clinical and social settings for early detection and proper management of amblyopia.

Keywords: Amblyopia; Children; Prevalence; Refractive Errors; Risk Factor.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Outcomes of some studies on the prevalence of amblyopia in the Kingdom of Saudi Arabia
Figure 2
Figure 2
Global prevalence of amblyopia from various studies including the current study

References

    1. Ciuffreda KJ, Levi DM, Selenow A. Amblyopia: Basic and clinical aspects. 1st ed. Boston, MA: Butterworth-Heinemann; 1991. pp. 343–48.
    1. Basic and Clinical Science Course: Pediatric Ophthalmology and Strabismus. 2nd ed. London: Willey-Blackwell; 1997. American Academy of Ophthalmology. Amblyopia; pp. 259–65.
    1. [Last accessed on 2009 Jan 08]. Available from: .
    1. Hatt S, Antonio-Santos A, Powell C, Vedulla SS. Interventions for stimulus deprivation amblyopia. Cochrane Database Syst Rev. 2006;3:CD005136.
    1. Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, et al. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111:2076–85.
    1. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: Experience of the amblyopia treatment study. Am J Ophthalmol. 2003;136:630–9.
    1. Lam GC, Repka MX, Guyton DL. Timing of amblyopia therapy relative to strabismus surgery. Ophthalmology. 1993;100:1751–6.
    1. Reese PD, Weingeist TA. Pars plana management of ectopialentis in children. Arch Ophthalmol. 1987;105:1202–4.
    1. American Academy of Pediatrics and American Academy of Ophthalmology. Joint Policy Statement. Protective Eyewear for Young Athletes. 2003. [Last accessed on 2007 Feb 27]. Available from:
    1. Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: A randomized trial. Arch Ophthalmol. 2008;126:1634–42.
    1. Hertle RW, Scheiman MM, Beck RW, Chandler DL, Bacal DA, Birch E, et al. Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007;125:655–9.
    1. The Pediatric Eye Disease Investigator Group. A randomized clinical trial of the treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123:437–47.
    1. The Pediatric Eye Disease Investigator Group. A Prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol. 2004;137:581–3.
    1. Wick B, Cotter S, Scheiman M. Anisometropic Amblyopia: Is the patient ever too old to treat? Optom Vis Sci. 1992;69:866–78.
    1. Li RW, Ngo C, Nguyen J, Levi DM. Video-game play induces plasticity in the visual system of adults with amblyopia. PLoS Biol. 2011;9:e1001135.
    1. American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus Pannel. Preferred Practice Pattern® Guidelines Amblyopia. San Francisco. American Academy of Ophthalmology. 2012. [Last accessed 2013 Jan 15]. Available from: .
    1. Older Children Can Benefit From Treatment For Childhood's Most Common Eye Disorder. NEI Press release. 2005. Apr 11, [Last accessed 2013 Jan 18]. Available from: .
    1. Isenberg SJ. Amblyopia can be treated without occlusion or atropine. Ophthalmology. 2006;113:893.
    1. Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006;113:895–903.
    1. Stewart CE, Moseley MJ, Fielder AR, Stephens DA. MOTAS Cooperative. Refractive adaptation in amblyopia: Quantification of effect and implications for practice. Br J Ophthalmol. 2004;88:1552–6.
    1. Awan M, Proudlock FA, Gottlob I. A randomized controlled trail of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435–9.
    1. Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for amblyopia in children. Ophthalmology. 2006;113:904–12.
    1. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603–11.
    1. Al-Assaf A, Fatani R. Vision screening of preschool children in Riyadh. Saudi J Ophthalmol. 1994;8:9–14.
    1. Abolfotouh M, Aheem Y. Ocular disorders Among school boys in a high altitude area of Saudi Arabia. Saudi J Ophthalmol. 1994;8:20–4.
    1. Al-Faran MF. Prevalence of ocular disorders among school boys in five villages in Al-Baha Region. Ann Saudi Med. 1992;12:3–7.
    1. Kahn MU, Hossain MA, Abu-Zeid H, Eid O. Prevalence of eye problems and visual defects in school children of Abha. Saudi Bull Ophthalmol. 1989;4:181–4.
    1. Multi-ethnic Pediatric Eye Disease Study Group. Prevalence of amblyopia and strabismus in African American and Hispanic children aged 6 to 72 months. Ophthalmology. 2008;115:1229–36.
    1. Varma R, Deneen J, Cotter S, Paz SH, Azen SP, Tarczy-Hornoch K, et al. Multi-Ethnic Pediatric Eye Disease Study Group. The multiethnic pediatric eye disease study: Design and methods. Ophthalmic Epidemiol. 2006;13:253–62.
    1. Pararajasegaram R. Vision 2020-the right to sight: From strategies to action. Am J Ophthalmol. 1999;128:359–60.
    1. Newsham D. The effect of recent amblyopia research on current practice in the UK. Br J Ophthalmol. 2010;94:1352–7.
    1. Bardisi WM, Bakr M, Sadiq B. Vision screening of preschool children in Jeddah, Saudi Arabia. Saudi Med J. 2002;23:445–9.
    1. Awan MA, Ahmad I, Khan AA. Prevalence of amblyopia among government middle school children in city of Lahore, Pakistan International Journal for Agro Veterinary and Medical Sciences. IJAVMS. 2010;4:41–6.
    1. Multi-Ethnic Pediatric Eye Disease Study Group. Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the multi-ethnic pediatric eye disease study. Ophthalmology. 2008;115:1229–36.
    1. Williams C, Northstone K, Howard M, Harvey I, Harrad RA, Sparrow JM. Prevalence and risk factors for common vision problems in children: Data from the ALSPAC study. Br J Ophthalmol. 2008;92:959–64.
    1. Pai AS, Rose KA, Leone JF, Sharbini S, Burlutsky G, Varma R, et al. Amblyopia prevalence and risk factors in Australian preschool C American Academy of Ophthalmology. Amblyopia children. Ophthalmology. 2012;119:138–44.
    1. Drover JR, Kean PG, Courage ML, Adams RJ. Prevalence of amblyopia and other vision disorders in young Newfoundland and Labrador children. Can J Ophthalmol. 2008;43:89–94.
    1. Yekta A, Fotouhi A, Hashemi H, Dehghani C, Ostadimoghaddam H, Heravian J, et al. The prevalence of anisometropia, amblyopia and strabismus in school children of Shiraz, Iran. Strabismus. 2010;18:104–10.
    1. Chia A, Dirani M, Chan Y, Gazzard G, Eong KA, Selvaraj P, et al. Prevalence of amblyopia and strabismus in young Singaporean Chinese children. Invest Ophthalmol Vis Sci. 2010;51:3411–4317.
    1. Sapkota K, Pirouzian A, Matta NS. Prevalence of amblyopia and patterns of refractive error in the amblyopic children of a tertiary eye care center of Nepal. Nepal J Ophthalmol. 2013;5:38–44.
    1. Friedman DS, Repka MX, Katz J, Giordano L, Ibironke J, Hawse P, et al. Prevalence of amblyopia and strabismus in white and African-American children aged 6 through 71 months: The Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009;116:2128–34.
    1. Wang Y, Liang YB, Sun LP, Duan XR, Yuan RZ, Wong TY, et al. Prevalence and causes of amblyopia in a rural adult population of Chinese the Handan Eye Study. Ophthalmology. 2011;118:279–83.
    1. Shaw DE, Fielder AR, Minshull C, Rosenthal AR. Amblyopia--factors influencing age of presentation. Lancet. 1988;2:207–9.
    1. Woodruff G, Hiscox F, Thompson JR, Smith LK. The presentation of children with amblyopia. Eye (Lond) 1994;8:623–6.
    1. Chua BE, Johnson K, Martin F. A retrospective review of the associations between amblyopia type, patient age, treatment compliance and referral patterns. Clin Experiment Ophthalmol. 2004;32:175–9.
    1. Von Noorden GK, Campos EC, editors. Binocular vision and ocular motility: Theory and management of strabismus. 6th ed. St. Louis: Mosby; 2011. pp. 246–7.
    1. Hussein MA, Coats DK, Muthialu A, Cohen E, Paysse EA. Risk factors for treatment failure of anisometropic amblyopia. J AAPOS. 2004;8:429–34.
    1. Leon A, Donahue SP, Morrison DG, Estes RL, Li C. The age-dependent effect of anisometropia magnitude on anisometropic amblyopia severity. J AAPOS. 2008;12:150–6.
    1. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268–78.
    1. US Preventive Services Task Force. Screening for vision impairment in children younger than age 5 years: Recommendation statement. Ann Fam Med. 2004;2:263–6.
    1. Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friendman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS. 2000;4:194–9.
    1. Daw NW. Critical period and amblyopia. Arch Ophthalmol. 1998;116:502–5.
    1. Stewart CE, Fielder AR, Stephen DA, Mosely MJ. Treatment of unilateral amblyopia: Factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005;46:3152–60.
    1. Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systemic review and economic evaluation. Health Technol Assess. 2008;12(25)
    1. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075–87.
    1. Flynn JT, Woodruff G, Thompson JR, Hiscox F, Feuer W, Schiffman J, et al. The therapy of amblyopia: An analysis comparing the results of amblyopia therapy utilizing the two pooled data sets. Trans Am Ophthalmol Soc. 1999;97:373–90.
    1. Williams C, Northstone K, Harrad RA, Aparrow JM, Harvey I. ALSPAC Study Team. Amblyopia treatment outcomes after screening before or at age 3 years: Follow up from randomised trial. BMJ. 2002;324:1549.
    1. Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I. ALSPAC Study Team. Amblyopia treatment outcomes after preschool screening v school entry screening: Observational data from a prospective cohort syudy. Br J Ophthalmol. 2003;87:988–93.
    1. Clarke MP, Wright CM, Hrisos S, anderson JD, Henderson J, Richardson SR. Randomized controlled trial of treatment of unilateral visual impairment detected at preschool visual screening. BMJ. 2003;327:1251–4.
    1. Holmes JM, Lazer EL, Melia BM, Astle WF, Dagi LR, Donahue SP, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011;129:1451–7.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する